Back

Growth hormone replacement therapy in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

4 April 2025 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Pharmacological and non-pharmacological interventions in heart failure Pharmacotherapy EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Associate Professor Alberto Maria Marra

University of Naples Federico II, Naples (Italy)

5 More presentations in this session

Presentation thumbnail
Eccentric overload training in patients with heart failure: assessing delayed onset muscle soreness to determine feasibility
Mr S. Naessens (Edegem, BE)
Abstract Slides
Presentation thumbnail
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis
Doctor V. Lanari (Milan, IT)
Abstract Slides
Presentation thumbnail
Heart failure and early cardiac rehabilitation: pilot experience and definition of the patient journey
Doctor F. Di Salvo (Milan, IT)
Abstract Slides
Presentation thumbnail
The correlation between the modifiable risk factors in hospital readmissions and critical phase in heart failure patients
Doctor A. Lacraru (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Effects of an in-hospital physical activity motivational programme in chronic heart failure or chronic obstructive pulmonary disease patients undergoing rehabilitation: a randomized controlled trial
Doctor C. Simonelli (Lumezzane, IT)
Abstract Slides

Access the full session

Session thumbnail
Pharmacological and non-pharmacological interventions in heart failure

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 15:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources